Source:http://linkedlifedata.com/resource/pubmed/id/19055860
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2008-12-5
|
pubmed:abstractText |
Normal T cells can mediate antileukemic reactivity after allogeneic stem cell transplantation and T cell targeting immunotherapy is now considered for patients receiving conventional chemotherapy. This antileukemic reactivity is most effective in patients with a low leukemia cell burden, and this burden is expected to be lowest early after transplantation/chemotherapy when patients are cytopenic. Local T cell recruitment will then be essential for the efficiency of the antileukemic response. In this context, the authors compared the chemokine receptor expression for T cells derived from healthy individuals and acute myelogenous leukemia patients with therapy-induced cytopenia after conventional chemotherapy or allogeneic stem cell transplantation. Circulating CD3(+) T cells showed the same chemokine receptor expression for all three groups: CCR1(low), CCR2(low), CCR3(low), CCR4(intermediate), CCR5(intermediate), CCR7(low/intermediate), CXCR2(low), CXCR3(intermediate), and CXCR4(high). Thus, only minor differences between the groups were observed when comparing individual receptors, and we therefore conclude that the chemokine receptor profiles of circulating CD3(+) T cells show no qualitative and only minor quantitative differences for these three groups.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1607-8454
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
329-32
|
pubmed:meshHeading |
pubmed-meshheading:19055860-Adult,
pubmed-meshheading:19055860-Aged,
pubmed-meshheading:19055860-Antigens, CD3,
pubmed-meshheading:19055860-Case-Control Studies,
pubmed-meshheading:19055860-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:19055860-Humans,
pubmed-meshheading:19055860-Leukemia, Myeloid, Acute,
pubmed-meshheading:19055860-Middle Aged,
pubmed-meshheading:19055860-Pancytopenia,
pubmed-meshheading:19055860-Receptors, Chemokine,
pubmed-meshheading:19055860-T-Lymphocytes,
pubmed-meshheading:19055860-Transplantation, Homologous
|
pubmed:year |
2008
|
pubmed:articleTitle |
Circulating T cells derived from acute leukemia patients with severe therapy-induced cytopenia express a wide range of chemokine receptors.
|
pubmed:affiliation |
Division for Hematology, Department of Medicine, Haukeland University Hospital and The University of Bergen, Bergen, Norway.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|